Detalhe da pesquisa
1.
Outcomes and clinical characteristics of the compassionate use of plitidepsin in COVID-19 patients with solid tumours, haematological malignancies or anti-CD20 antibody treatment.
Infect Dis (Lond)
; 56(7): 575-580, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38743059
2.
Outcomes and clinical characteristics of the compassionate use of plitidepsin for immunocompromised adult patients with COVID-19.
Int J Infect Dis
; 135: 12-17, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37481109